The invention provides compounds of Formula I, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, B, D, R
1
, R
2
, R
4
and R
5
are defined herein, a pharmaceutical composition that includes a compound of Formula I and methods of use thereof
[EN] CINNOLINE DERIVATIVES AS AS BTK INHIBITORS<br/>[FR] DÉRIVÉS DE CINNOLINE EN TANT QU'EN TANT QU'INHIBITEURS DE LA BTK
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2013148603A1
公开(公告)日:2013-10-03
Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined in the specification. The compounds are inhibitors of Bruton's tyrosine kinase (BTK). This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders or conditions associated with BTK.
The invention comprises lubricating compositions and hydraulic fluids containing N,N′-diaryl-m-phenylene diamine compounds that impart good levels of oxidation inhibition in the lubricants and hydraulic fluids.